Fang Xu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Cerebrospinal Fluid

High Resolution Mass Spectrometry

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Wentao Zhu, Wenqian Zhang, Jian Chen, Yichen Tong, Fang Xu, Ji-Yan Pang
Discovery of Effective Dual PROTAC Degraders for Neurodegenerative Disease-Associated Aggregates. Journal of medicinal chemistry 67 (5) (2024)
Jian Chen, Wentao Zhu, Wenqian Zhang, Yichen Tong, Fang Xu, Ji-Yan Pang
Discovery of the First Potent DYRK2 Proteolysis Targeting Chimera Degraders. ACS medicinal chemistry letters 15 (5) (2024)
Wentao Zhu, Wenqian Zhang, Jian Chen, Yichen Tong, Fang Xu, Ji-Yan Pang
Discovery of Effective Dual PROTAC Degraders for Neurodegenerative Disease-Associated Aggregates. Journal of medicinal chemistry 67 (5) (2024)
Wentao Zhu, Wenqian Zhang, Jian Chen, Yichen Tong, Fang Xu, Ji-Yan Pang
Discovery of Effective Dual PROTAC Degraders for Neurodegenerative Disease-Associated Aggregates. Journal of medicinal chemistry (2024)
Jian Chen, Wentao Zhu, Wenqian Zhang, Yichen Tong, Fang Xu, Ji-Yan Pang
Discovery of the First Potent DYRK2 Proteolysis Targeting Chimera Degraders. ACS medicinal chemistry letters 15 (5) (2024)
Yichen Tong, Wentao Zhu, Jian Chen, Wenqian Zhang, Fang Xu, Ji-Yan Pang
Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides. Journal of medicinal chemistry (2023)
Yichen Tong, Wentao Zhu, Jian Chen, Tianzhi Wen, Fang Xu, Ji-Yan Pang
Discovery of Small-Molecule Degraders for Alpha-Synuclein Aggregates. Journal of medicinal chemistry (2023)
Fang Xu, Xin Zhang, Zhipeng Chen, Sheng He, Jing Guo, Lei Yu, Yongjin Wang, Caiyun Hou, Hawaa Ai-Furas, Zongyao Zheng, Jeff B Smaill, Adam V Patterson, Zhi-Min Zhang, Liang Chen, Xiaomei Ren, Ke Ding
Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells. Journal of medicinal chemistry 65 (20) (2022)
Hualin Zhang, Ruliang Xie, Hawaa Ai-Furas, Yupeng Li, Qingxia Wu, Jian Li, Fang Xu, Tianfeng Xu
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting Del19/T790M/C797S Mutation. ACS medicinal chemistry letters 13 (2) (2022)
Wentao Zhu, Yichen Tong, Qianyi Feng, Fang Xu, Ji-Yan Pang
Discovery of Novel Polycyclic Phloroglucinols via an Improved One-Pot Method. ACS omega 7 (50) (2022)
Wentao Zhu, Yichen Tong, Qianyi Feng, Fang Xu, Ji-Yan Pang
Discovery of Novel Polycyclic Phloroglucinols via an Improved One-Pot Method. ACS omega 7 (50) (2022)
Yichen Tong, Wentao Zhu, Tianzhi Wen, Zere Mukhamejanova, Fang Xu, Qi Xiang, Ji-Yan Pang
Xyloketal B Reverses Nutritional Hepatic Steatosis, Steatohepatitis, and Liver Fibrosis through Activation of the PPARα/PGC1α Signaling Pathway. Journal of natural products 85 (7) (2022)
Yichen Tong, Zere Mukhamejanova, Yinglin Zheng, Tianzhi Wen, Fang Xu, Ji-Yan Pang
Marine-Derived Xyloketal Compound Ameliorates MPP+-Induced Neuronal Injury through Regulating of the IRE1/XBP1 Signaling Pathway. ACS chemical neuroscience 12 (16) (2021)